Investors
Jenrin Discovery was founded by former DuPont Pharmaceuticals scientists, and received seed-stage and subsequent funding from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania, and Ben Franklin Technology Partners of Southeastern Pennsylvania.
Venture funding was received from Research Corporation Technologies, Themelios Venture Partners, Gardner-Lewis Asset Management and BrookDell Partners.
Private investor funding was received from Donald Gleklen, J.D.
A BriDGs Grant from the National Institutes of Health, NCATS Program, also provided pre-clinical development funding.
Copyright 2017 Jenrin Discovery - All Rights Reserved